Swen JJ - Search Results

1

UGT1A1 genotype-guided dosing of irinotecan: time to prioritize patient safety.

Peeters SL, Deenen MJ, Thijs AM, Hulshof EC, Mathijssen RH, Gelderblom H, Guchelaar HJ, Swen JJ. Peeters SL, et al. Among authors: swen jj. Pharmacogenomics. 2023 Jun;24(8):435-439. doi: 10.2217/pgs-2023-0096. Epub 2023 Jul 20. Pharmacogenomics. 2023. PMID: 37470120

2

Translating pharmacogenomics: challenges on the road to the clinic.

Swen JJ, Huizinga TW, Gelderblom H, de Vries EG, Assendelft WJ, Kirchheiner J, Guchelaar HJ. Swen JJ, et al. PLoS Med. 2007 Aug;4(8):e209. doi: 10.1371/journal.pmed.0040209. PLoS Med. 2007. PMID: 17696640 Free PMC article. Review.

3

Use of plasmid-derived external quality control samples in pharmacogenetic testing.

van der Straaten T, Swen J, Baak-Pablo R, Guchelaar HJ. van der Straaten T, et al. Pharmacogenomics. 2008 Sep;9(9):1261-6. doi: 10.2217/14622416.9.9.1261. Pharmacogenomics. 2008. PMID: 18781854 Free article. Review.

4

Effect of CYP2C9 polymorphisms on prescribed dose and time-to-stable dose of sulfonylureas in primary care patients with Type 2 diabetes mellitus.

Swen JJ, Wessels JA, Krabben A, Assendelft WJ, Guchelaar HJ. Swen JJ, et al. Pharmacogenomics. 2010 Nov;11(11):1517-23. doi: 10.2217/pgs.10.121. Pharmacogenomics. 2010. PMID: 21121772

5

Genetic risk factors for type 2 diabetes mellitus and response to sulfonylurea treatment.

Swen JJ, Guchelaar HJ, Baak-Pablo RF, Assendelft WJ, Wessels JA. Swen JJ, et al. Pharmacogenet Genomics. 2011 Aug;21(8):461-8. doi: 10.1097/FPC.0b013e3283478173. Pharmacogenet Genomics. 2011. PMID: 21633322

6

Comment: global formulary review: how do we integrate pharmacogenomic information?

Swen JJ, Guchelaar HJ. Swen JJ, et al. Ann Pharmacother. 2011 Jul;45(7-8):1030; author reply 1030-1. doi: 10.1345/aph.1P557a. Epub 2011 Jul 20. Ann Pharmacother. 2011. PMID: 21775697 No abstract available.

7

Alternative methods to a TaqMan assay to detect a tri-allelic single nucleotide polymorphism rs757210 in the HNF1β gene.

Swen JJ, Baak-Pablo RF, Guchelaar HJ, van der Straaten T. Swen JJ, et al. Clin Chem Lab Med. 2011 Oct 21;50(2):279-84. doi: 10.1515/CCLM.2011.758. Clin Chem Lab Med. 2011. PMID: 22022982

8

The challenges of developing a 'medical-grade' genome.

van der Straaten T, Guchelaar HJ, Swen JJ. van der Straaten T, et al. Among authors: swen jj. Pharmacogenomics. 2012 Mar;13(4):369-72. doi: 10.2217/pgs.12.6. Pharmacogenomics. 2012. PMID: 22379992 No abstract available.

9

Genetic risk factors for drug-induced liver injury in rheumatoid arthritis patients using low-dose methotrexate.

Dávila-Fajardo CL, Swen JJ, Cabeza Barrera J, Guchelaar HJ. Dávila-Fajardo CL, et al. Among authors: swen jj. Pharmacogenomics. 2013 Jan;14(1):63-73. doi: 10.2217/pgs.12.183. Pharmacogenomics. 2013. PMID: 23252949 Review.

10

Pharmacogenetics in transplant patients: mind the mix.

Ten Brink MH, van der Straaten T, Bouwsma H, Baak-Pablo R, Guchelaar HJ, Swen JJ. Ten Brink MH, et al. Among authors: swen jj. Clin Pharmacol Ther. 2013 Oct;94(4):443-4. doi: 10.1038/clpt.2013.110. Epub 2013 May 24. Clin Pharmacol Ther. 2013. PMID: 23708744 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

178 results

Search Page